There is three cancers for which high DCBLD1 expression has been associated to a worse overall survival and upregulation of the integrin signaling pathway: NSCLC, invasive breast carcinoma and HNSCC, which was previously published2. Here, DCBLD1 is linked to non-small cell lung carcinoma.